UBS analyst Timothy Arcuri lowered the firm’s price target on Texas Instruments (TXN) to $215 from $225 and keeps a Buy rating on the shares. The Q1 results and positive underlying commentary for Q2 support the firm’s thesis prior to April 2 “Liberation Day” that Texas Instruments is a share gainer in a cyclical recovery just starting to take shape, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TXN:
- Texas Instruments price target lowered to $215 from $250 at KeyBanc
- Cautious Outlook on Texas Instruments: Sell Rating Amid Valuation Concerns and Macroeconomic Risks
- Texas Instruments Reports Strong Q1 2025 Results
- Texas Instruments Hold Rating: Balancing Strong Performance with Tariff and Valuation Concerns
- Texas Instruments downgraded to Hold from Buy at Summit Insights